BACKGROUND A percutaneous approach with transcatheter aortic valve replacement (TAVR) and percutaneous
percutaneous coronary intervention (PCI) versus matched control subjects. There was no difference in 1-year mortality in patients undergoing TAVR plus LM PCI compared with matched control subjects.
Chakravarty et al. Tables 1 and 2 .
OUTCOMES OF TAVR PLUS LM PCI VERSUS TAVR ALONE IN MATCHED PATIENTS.
Baseline characteristics of the TAVR plus LM PCI cohort (n ¼ 128) and matched control subjects (n ¼ 128) are summarized in Values are mean AE SD or n (%).
Abbreviations as in Table 1 .
Chakravarty et al. 
PREDICTORS OF MORTALITY AFTER TAVR PLUS LM
PCI. The univariate predictors of mortality in the 176 patients undergoing planned TAVR plus LM PCI are summarized in Table 6 . 
